ChatGPT Gets Read-Only Access to 325M Patient Records

Good morning, HealthTech insiders. The patient chart, the operating room, the radiology booking queue, three of the most friction-filled access points in clinical care got a structural update yesterday. OpenAI landed inside Epic. Stryker put the OR data in a headset and completed the first surgery. And $220M closed to build what blood testing has had for 40 years: a national routing backbone for the 600 million diagnostic imaging scans Americans get every year.

The common thread isn't a new algorithm. It's plumbing. The capability already existed; what was missing was the connection between that capability and the clinician standing in front of a patient. This week's pattern is about who gets to build that connection, and how fast. The accountability question, who's responsible when the pipe delivers something wrong, is the one trailing behind.

In today's Signal:

• OpenAI connects ChatGPT for Healthcare to Epic records covering 325M patients; read-only, HIPAA-compliant, live at UCSF, HCA, Cedars-Sinai, and six other launch partners.

• Stryker completes the first surgery using Apple Vision Pro in the OR; FDA-authorized spatial computing app bringing arthroscopic video + CT imaging into the surgeon's field of view.

• Scan.com raises $220M to build the national imaging API the US has been missing; 600M scans a year, 85% still booked by phone.

• Follow the money: both major deals target the transition layer; routing a patient to the right place after a clinical decision is made.

• Quick Hits: LeanTaaS closes the bed-discharge loop with Aidin acquisition; NHS AI scribe errors spread to national press.

BIG TECH
1. OpenAI just walked ChatGPT into the patient chart.

The signal: On September 1, OpenAI launched an integration connecting ChatGPT for Healthcare directly to Epic, the software most US hospitals run on, holding data for 325 million patients. Clinicians can now summarize records, spot changes since the last visit, and prepare for appointments, all without leaving the chart.

The details:

• The integration is read-only. ChatGPT cannot write anything back to the patient record. It surfaces notes, labs, medications, and specialist documentation that the clinician already has permission to see. A Business Associate Agreement is required for HIPAA-compliant use.

• Launch partners include UCSF Health, HCA Healthcare, Cedars-Sinai, AdventHealth, Baylor Scott & White Health, Boston Children's Hospital, and Memorial Sloan Kettering. UCSF CEO Suresh Gunasekaran described UCSF as a pilot partner.

• A companion Healthcare Public Data plugin connects to nine official sources: ClinicalTrials.gov, PubMed, DailyMed, RxNorm, and CMS Coverage. Physicians rated 99.1% of responses safe across 4,363 evaluations — OpenAI's own evaluation, not independent.

Why it matters: Epic has historically been a walled garden, data in, very little out without Epic's approval. OpenAI just got a read-only window. The liability and audit-trail questions are real, but the access itself is a structural shift: ChatGPT is no longer outside the clinical workflow asking to be let in. Watch how Epic responds when the garden gets more doors than it planned for.

MEDICAL DEVICES
2. A surgeon just wore the data instead of looking for it.

The signal: On September 1, Stryker completed the first surgery using SportSuite Vision on Apple Vision Pro at Duke Health, making it the first FDA-authorized intraoperative spatial computing application ever used in a live surgical case.

The details:

• SportSuite Vision received FDA De Novo authorization on July 17, 2026. The first live case was a hip arthroscopy performed by Dr. Chad Mather III, MD, MBA, an orthopedic surgeon at Duke Health.

• The app displays arthroscopic video, HipCheck bone morphology data, HipMap FAI (femoroacetabular impingement) analysis, and CT imaging inside the surgeon's field of view via a see-through AR headset — replacing the wall-mounted monitors that usually sit beside the table during arthroscopic procedures.

• Matt Moreau, VP and GM of Stryker Sports Medicine, described this as a step toward 'a truly connected digital operating room' where data flows to the surgeon rather than the surgeon turning away from the patient to find it.

Why it matters: The Apple Vision Pro's consumer trajectory has stalled. Its surgical one just got a much clearer path. Stryker holds the De Novo template that every competitor will now cite when filing their own intraoperative AR applications. The more interesting question is whether this stays in elective orthopaedics or moves toward higher-stakes surgical settings where a misread overlay has bigger consequences.

CAPITAL & DEALS
3. Imaging finally gets the API that lab testing built 40 years ago.

The signal: Scan.com raised $220M ($90M Series C equity led by Noteus Partners, plus $130M in debt facilities) to build the national infrastructure layer for US diagnostic imaging. CEO Charlie Bullock: 'Labs got that decades ago with Quest and Labcorp. Imaging never did.'

The details:

• The US runs approximately 600 million medical imaging scans a year, with roughly 85% of outpatient bookings still handled by phone and fax. Scan.com's two-way API connects payers, employers, and digital health platforms to imaging centers with transparent pricing and results returned within 48 hours via subspecialty radiologists.

• Revenue doubled over the past year to a $165M annualized run rate. Already the UK's largest private imaging network; expanded into the US in 2023. More than 900,000 patients have used the platform globally.

• The $130M debt tranche is specifically for M&A and working capital — Scan.com is buying imaging center network capacity, not just building software. Equity: Aviva, Concord Health Partners, YZR Capital, Oxford Capital.

Why it matters: Imaging is 6-11% of all US medical spend, and the gap between neighboring centers (same scan, two to three times the price) is a pure coordination failure, not a clinical one. The debt load is the honest signal here: Scan.com is acquiring the network, not just building software to point at it. The lab testing comparison isn't hyperbole. It's the template.

💰 FOLLOW THE MONEY

• The deals: Scan.com closed $220M ($90M Series C equity, $130M debt) for diagnostic imaging infrastructure, the largest HealthTech raise of the week. LeanTaaS acquired Aidin (terms undisclosed), a care transition platform coordinating 2 million annual referrals across 200+ hospitals and 21,000 post-acute providers.

• The pattern: Both deals target the transition layer, getting a patient routed to the right place after a clinical decision is already made. Scan.com routes imaging orders; Aidin routes hospital discharges. Neither is building new clinical AI capability. Both are fixing the hand-off that existing AI still can't execute reliably. This week's capital is going to the pipe, not the algorithm.

🩺 THE CLINICIAN’S SIGNAL

• On the OpenAI/Epic integration: Read-only access with a Business Associate Agreement is the compliance floor, not the ceiling. The clinical question is what happens when an AI-generated summary influences a decision and the source note it drew from was itself incomplete or wrong. That audit trail needs to exist before adoption scales.

• On Stryker's Vision Pro in the OR: Surgeons already manage multiple cluttered monitors during arthroscopy. Spatial computing solves a real ergonomics problem. The liability template gets set the first time an AR overlay misreads anatomy in a live case, and that moment is now closer than it was 48 hours ago.

• On Scan.com's imaging network: Faster routing means faster results reaching referring clinicians, but 48-hour turnaround at volume shifts the constraint from booking to radiologist bandwidth. Watch whether teleradiology capacity actually scales with the network, or whether speed at the front end creates a new bottleneck at the reporting stage.

🛠️ Trending HealthTech AI Tools & Startups

• ChatGPT for Healthcare (OpenAI): Epic EHR integration, read-only HIPAA-compliant; 99.1% physician safety rating across 4,363 evaluations.

• SportSuite Vision (Stryker): First FDA De Novo intraoperative AR app for Apple Vision Pro; hip arthroscopy at Duke Health, Sept 1.

• CPETWise (Medibyt): FDA 510(k) cleared Sept 1; 50%+ reduction in cardiopulmonary exercise test interpretation time; deploying at Columbia, UCLA, UW.

• iQueue + Aidin (LeanTaaS): Predictive bed management + post-acute referral coordination; 200+ hospitals, 21,000 post-acute providers.

• Scan.com: Led by Charlie Bullock (co-founder and CEO); $165M ARR, 900,000 patients globally; UK's largest private imaging network, now building US national infrastructure.

• Medibyt: Led by Or Inbar (CEO and co-founder); FDA-cleared CPET diagnostics AI; Columbia, UCLA, University of Washington, Sheba Medical Center.

• Aidin: Founded by Russell Graney; care transition coordination platform; now integrated into LeanTaaS iQueue.

• BEACON-Neuro.AI: Led by Dr. Raj Dhar (WashU Medicine); FDA Breakthrough Device for cerebral edema prediction; raising $3.2M seed.

📣 Highlights: Events, Lists & Deep Dives

• 📖 Trending Deep Dive: Epic + OpenAI — What Read-Only Actually Means for Clinical Liability (thehealthtechsignal.com)

• 🏆 HealthTech List: Top 10 Diagnostic Imaging AI Platforms to Watch in 2026 (thehealthtechsignal.com)

• 🔬 Diagnostic Tech: Spatial Computing in Surgery — What Comes After Stryker's First Case? (thehealthtechsignal.com)

• 📅 Industry Calendar: September HealthTech Events — HLTH, RSNA prep, FDA comment deadlines (thehealthtechsignal.com/events)

That's it for today!

Three moves yesterday, one underlying pattern: the infrastructure of clinical care is being rewired at the access layer. OpenAI inside Epic, a headset in the OR, an imaging API for a market running on fax machines. None of it is the breakthrough algorithm headline. All of it is the harder, more durable work.

The question I'd be watching is simple: access is getting faster. Is accountability moving at the same speed?

Tell me which of today's moves you think matters most, and where you think the accountability conversation actually needs to happen.

See you tomorrow,

Dr. Dereck Mush, MD, MBA

The HealthTech Signal is independently funded. Sponsorships help us invest in better reporting, research, and a stronger newsletter for our readers. Want to reach HealthTech founders & executives while supporting the Signal? Get in touch.

Was this email forwarded to you? Sign up here.